Cell & Gene Therapy Bioprocessing & Commercialization is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Jon A. Rowley, Ph.D.
Founder & Chief Product Officer at RoosterBio Inc.

Profile

Jon has had a successful scientific career at the intersection of Tissue Engineering, Biomaterials Science, Stem Cell Science, and the translation of cell-based technologies into commercializable products.  His last 10 years has been focusing on applying Manufacturing Sciences to cellular therapies and engineered tissues, where scale-up biomanufacturing technologies had to be applied to stem cells to manufacture at volumes consistent with commercial scale while not losing the critical biological functions that make stem cells therapeutically active.  Jon is considered a thought leader in the Regenerative Medicine field has been very active in sharing his research, and thoughts on technology direction and roadmaps.  He has championed solution-focused R&D aimed at solving the industry’s biggest challenges, including driving the cost of therapeutic cells down to increase the chance of building a sustainable industry.  Jon keynoted several major Cell Therapy Manufacturing conferences and has over 15 publications in the last 10 years, as well as over 75 conference presentations since 2005.  Jon continues his quest at his start-up, RoosterBio, where he and his team are working to simplify adult stem cell technology to increase adoption of new biomanufacturing technologies such as 3D bioprinting, and accelerate the development of tomorrow’s next generation high tech regenerative medicine products.

Agenda Sessions

  • Exosomes and their potential for scalable manufacturing platforms

    ,

Speakers at this event